Brits On The Brink Of Bankruptcy?

Strong measures to save Imperial College from indirect costs have ruffled scientists’ feathers LONDON--When the tall, spare frame of David Thomas glides into their laboratories, even the crustiest dons at London University’s Imperial College quake inside their tweed coats. For Thomas is the college’s ghost of Christmas future, warning of impending ruin unless scientists mend their financial ways. His message, preached with Welsh fervor, is simple. Imperial College and other

Written byDavid Fishlock
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Strong measures to save Imperial College from indirect costs have ruffled scientists’ feathers

LONDON--When the tall, spare frame of David Thomas glides into their laboratories, even the crustiest dons at London University’s Imperial College quake inside their tweed coats. For Thomas is the college’s ghost of Christmas future, warning of impending ruin unless scientists mend their financial ways.

His message, preached with Welsh fervor, is simple. Imperial College and other British research universities are in far worse shape than their U.S. counterparts. Instead of suffering from a few crumbling facilities, they are actually teetering on the brink of bankruptcy—and it’s the scientists’ own fault. “UK contractors have been getting us on the cheap for too long,” says Thomas, the college’s relatively new director of industrial liaison.

David Thomas is dragging reluctant scientists into a brave new era, one in which professors are viewed more like members of a management team ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies